Back to Search Start Over

The role of a behavioural medicine intervention in physiotherapy for the effects of rehabilitation outcomes in exercise-based cardiac rehabilitation (ECRA) - the study protocol of a randomised, controlled trial.

Authors :
Borg, Sabina
Öberg, Birgitta
Nilsson, Lennart
Söderlund, Anne
Bäck, Maria
Source :
BMC Cardiovascular Disorders; 5/25/2017, Vol. 17, p1-8, 8p, 1 Diagram
Publication Year :
2017

Abstract

<bold>Background: </bold>To help patients with coronary artery disease (CAD) benefit from the positive health effects attained by exercise-based cardiac rehabilitation (CR), adherence to these programmes according to international guidelines is important. Strategies to increase adherence to exercise-based CR are mainly an unexplored area. The objective of this study is to investigate the effects of a behavioural medicine intervention in physiotherapy, containing goal-setting, self-monitoring and feedback, with the aim of improving rehabilitation outcomes for exercise-based CR, compared with usual care.<bold>Methods: </bold>This is a randomised, controlled trial. A total of 160 patients with CAD will be included consecutively at the Coronary Care Unit at a university hospital in Sweden. Patients are randomised 1:1 using sealed envelopes to usual care or a behavioural medicine intervention in physiotherapy, in addition to usual care for 4 months. Outcome assessment at baseline, 4 and 12 months includes submaximal aerobic capacity (primary outcome), exercise adherence, muscle endurance, level of physical activity, biomarkers, anxiety and depression, health-related quality of life, patient enablement and self-efficacy (secondary outcomes).<bold>Discussion: </bold>This is the first study to evaluate the role of an integrated behavioural medicine intervention in exercise-based CR in the effects of rehabilitation outcomes. The results of this study will provide valuable information about the effect of these interventions in exercise-based CR and it has the potential to inform and assist in further treatment in secondary prevention for patients with CAD.<bold>Trial Registration: </bold>The study include all items from the World Health Organization Trial Registration Data Set.<bold>Trial Registration Number: </bold>NCT02895451, 2016-08-16, retrospectively registered. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712261
Volume :
17
Database :
Complementary Index
Journal :
BMC Cardiovascular Disorders
Publication Type :
Academic Journal
Accession number :
123254049
Full Text :
https://doi.org/10.1186/s12872-017-0557-7